V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210001965 | 210005606 | null | null | null | null | 2019-12-20 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101511594 |
| 210001967 | 210005608 | 1.63 | 89.4 | Adjuvant (A) | 2017-04-14 | 2017-05-05 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 100709019 |
| 210001969 | 210005610 | null | 66.95 | Neo-adjuvant (N) | null | 2019-01-12 | PACLITAXEL | 01 | N | PACLITAXEL | 101437916 |
| 210001971 | 210005612 | 1.62 | 50.4 | Neo-adjuvant (N) | 2019-01-22 | 2019-02-07 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100819643 |
| 210001972 | 210005613 | 1.67 | 97.3 | Adjuvant (A) | 2018-07-25 | 2018-08-16 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101672086 |
| 210001974 | 210005614 | 1.59 | 59 | Adjuvant (A) | null | 2017-03-31 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100027162 |
| 210001975 | 210005615 | 1.62 | 79.8 | Adjuvant (A) | 2016-11-09 | 2016-12-01 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100995890 |
| 210001976 | 210005616 | 1.54 | null | Adjuvant (A) | 2017-07-31 | 2017-08-09 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100351657 |
| 210001979 | 210005618 | 1.71 | 80.9 | Adjuvant (A) | 2017-07-19 | 2017-07-28 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101211817 |
| 210001980 | 210005619 | 1.71 | 60.95 | null | 2018-06-15 | 2018-06-17 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100913908 |
| 210001983 | 210005621 | null | 86.9 | null | 2017-10-03 | 2017-10-11 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 100503111 |
| 210001985 | 210005623 | 1.64 | null | Neo-adjuvant (N) | 2020-10-03 | 2020-10-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101008679 |
| 210001988 | 210005625 | 1.53 | 56 | Adjuvant (A) | 2018-08-17 | 2018-09-13 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100538406 |
| 210001989 | 210005626 | null | 88.9 | null | 2018-03-29 | 2018-04-20 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100262397 |
| 210001990 | 210005627 | 1.62 | 54 | Adjuvant (A) | 2018-04-25 | 2018-05-11 | PACLITAXEL | 02 | N | PACLITAXEL | 100182875 |
| 210001992 | 210005628 | 1.69 | 50.4 | Adjuvant (A) | 2019-05-18 | 2019-06-16 | Docetaxel | 02 | N | DOCETAXEL | 100767184 |
| 210001993 | 210005629 | 1.7 | 85.1 | Adjuvant (A) | 2018-08-03 | 2018-08-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100782001 |
| 210001994 | 210005630 | 1.47 | 100.6 | Adjuvant (A) | 2019-08-30 | 2019-09-16 | Docetaxel | 02 | N | DOCETAXEL | 100155303 |
| 210001998 | 210005632 | 1.56 | null | Adjuvant (A) | 2017-11-22 | 2017-11-22 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100237538 |
| 210001999 | 210005633 | 1.6 | 74.9 | Adjuvant (A) | 2019-11-12 | 2019-11-19 | Docetaxel | null | N | DOCETAXEL | 100201847 |
| 210002000 | 210005634 | 1.71 | 74.2 | Adjuvant (A) | null | 2018-06-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 100266618 |
| 210002001 | 210005635 | null | null | null | 2019-09-27 | 2019-09-27 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101718418 |
| 210002002 | 210005636 | 1.52 | null | Neo-adjuvant (N) | null | 2018-10-20 | Docetaxel | 02 | N | DOCETAXEL | 100530994 |
| 210002003 | 210005637 | 1.75 | 63.1 | Adjuvant (A) | null | 2018-03-29 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100566973 |
| 210002004 | 210005638 | 1.62 | null | Adjuvant (A) | 2018-07-06 | 2018-07-18 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100262163 |
| 210002005 | 210005639 | null | null | null | 2016-02-08 | 2016-02-19 | Trastuzumab | null | null | TRASTUZUMAB | 100768306 |
| 210002007 | 210005640 | 1.71 | 62 | Adjuvant (A) | 2016-07-05 | 2016-07-22 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100056255 |
| 210002009 | 210005642 | 1.59 | 66.95 | Adjuvant (A) | 2017-02-27 | 2017-05-17 | Paclitaxel 7 day | N | N | PACLITAXEL | 100403292 |
| 210002013 | 210005645 | null | null | null | 2019-05-21 | 2019-05-21 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101182837 |
| 210002015 | 210005646 | 1.6 | 68.8 | Adjuvant (A) | 2017-11-22 | 2017-11-29 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100946388 |
| 210002017 | 210005648 | null | 70.7 | null | 2018-05-18 | 2018-06-04 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 101096296 |
| 210002018 | 210005649 | 1.67 | null | Adjuvant (A) | null | 2019-06-23 | Docetaxel | 02 | N | DOCETAXEL | 101556270 |
| 210002020 | 210005650 | null | 88.9 | null | 2017-05-05 | 2017-05-20 | Trastuzumab | 02 | null | TRASTUZUMAB | 100407510 |
| 210002022 | 210005652 | null | 80.8 | null | 2019-02-01 | 2019-02-07 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100955881 |
| 210002023 | 210005653 | 1.65 | 69.6 | null | null | 2019-09-09 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101431357 |
| 210002024 | 210005654 | 1.72 | 82 | Palliative (P) | 2017-08-01 | 2017-08-16 | Trastuzumab Subcutaneous | null | Y | TRASTUZUMAB | 101531276 |
| 210002027 | 210005656 | 1.51 | 75.1 | Adjuvant (A) | 2016-08-31 | 2016-09-07 | Docetaxel | null | N | DOCETAXEL | 100990288 |
| 210002028 | 210005657 | 1.67 | 82.2 | Adjuvant (A) | 2016-11-28 | 2016-12-11 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101204194 |
| 210002029 | 210005658 | 1.59 | 57 | Palliative (P) | 2016-12-28 | 2017-01-05 | Trastuzumab | N | N | TRASTUZUMAB | 101637481 |
| 210002031 | 210005660 | 1.73 | 55.4 | Palliative (P) | null | 2017-07-03 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100704080 |
| 210002032 | 210005661 | null | null | null | 2017-07-03 | 2017-07-18 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100269791 |
| 210002034 | 210005662 | 1.67 | 93.8 | Adjuvant (A) | 2018-07-15 | 2018-07-30 | Docetaxel | 02 | N | DOCETAXEL | 101825786 |
| 210002036 | 210005663 | 1.65 | 79.4 | Palliative (P) | null | 2019-05-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100981321 |
| 210002038 | 210005665 | 1.68 | 78.1 | Adjuvant (A) | 2017-05-23 | 2017-06-12 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101316970 |
| 210002039 | 210005666 | 1.45 | 59.4 | Adjuvant (A) | null | 2017-07-09 | Paclitaxel 7 day | null | N | PACLITAXEL | 100408550 |
| 210002040 | 210005667 | 1.64 | 75.6 | Adjuvant (A) | 2020-07-08 | 2020-08-05 | PACLITAXEL | 02 | N | PACLITAXEL | 101390723 |
| 210002041 | 210005668 | 1.58 | 66.6 | Palliative (P) | 2018-11-21 | 2018-12-05 | PACLITAXEL | null | N | PACLITAXEL | 101772591 |
| 210002042 | 210005669 | 1.73 | 55.3 | Adjuvant (A) | null | 2019-07-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100360111 |
| 210002043 | 210005670 | 1.6 | 82.4 | Adjuvant (A) | 2016-09-07 | 2016-09-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100206101 |
| 210002044 | 210005671 | 1.55 | 79.4 | Neo-adjuvant (N) | 2019-03-02 | 2019-03-09 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101180133 |